Ikarian Capital’s Achieve Life Sciences ACHV Stock Holding History

Ikarian Capital’s Portfolio ACHV Stock Details ACHV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-174,714	Closed	-$990K	–	124
2023 Q1	$990K	Buy	+174,714	New	+$830K	0.22%	81
2021 Q2	–	Sell	-284,151	Closed	-$3.29M	–	213
2021 Q1	$3.29M	Hold	284,151	–	–	0.11%	163
2020 Q4	$2.3M	Hold	284,151	–	–	0.1%	145
2020 Q3	$2.38M	Buy	284,151 +101,224	+55%	+$928K	0.17%	105
2020 Q2	$1.45M	Buy	+182,927	New	+$1.46M	0.12%	115

Other funds holding ACHV

Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

BRWA

B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Ikarian Capital's ACHV Position: Q2 2023 in Review

Ikarian Capital sold out of Achieve Life Sciences (ACHV) in Q2 2023, closing a stake of 174,714 shares — an estimated $990K sold.

Ikarian Capital first reported a position in ACHV in Q2 2020 and held it in 5 quarters. The position peaked at $3.29M in Q1 2021. 39 funds tracked by Wall St. Rank hold ACHV as of Q2 2023.

Ikarian Capital reported no remaining Achieve Life Sciences position as of Q2 2023 after selling out during the quarter.
Ikarian Capital sold 174,714 Achieve Life Sciences shares in Q2 2023, an estimated $990K.
Ikarian Capital first reported a position in Achieve Life Sciences in Q2 2020 and held it in 5 quarters.
Ikarian Capital's Achieve Life Sciences position peaked at $3.29M in Q1 2021.
39 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2023.

Based on Ikarian Capital's 13F filing for Q2 2023, filed 14 Aug 2023.